Orthomatrix Inc.
This article was originally published in Start Up
Executive Summary
Orthomatrix hopes to fill a void in new technology for trauma implant devices.
You may also be interested in...
Orthopedic Devices
Favorable demographics, specifically an aging population and active younger generations, create opportunities for small companies to break into orthopedics, while consolidation is likely to continue among larger players.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.